Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.79 (
granzyme B
)
3,301
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In the present study, we demonstrate that a human homologue of Ufd2p (a yeast protein that catalyses the formation of long polyubiquitin chains, and is implicated in responses to environmental stress),
UFD2
(ubiquitin fusion degradation protein-2), is cleaved during apoptosis induced by multiple stimuli, including UVB irradiation, Fas ligation, staurosporine treatment and cytotoxic lymphocyte granule-induced death. Caspase 6 and
granzyme B
efficiently cleave
UFD2
[k(cat)/K(m)=(4-5) x 10(4) M(-1) x s(-1)] at Asp(123), whereas caspases 3 and 7 cleave
UFD2
approx. 10-fold less efficiently immediately upstream at Asp(109). Thus
UFD2
is added to the growing list of proteins with closely spaced caspase and
granzyme B
cleavage sites, suggesting the presence of a previously unrecognized, conserved motif. Both cleavage sites are contained and conserved within a novel 300-amino-acid N-terminal domain present in apparent
UFD2
orthologues in mice and zebrafish, but absent in all
UFD2
family members in lower eukaryotes. Full-length recombinant
UFD2
exhibited ubiquitin-protein ligase ('E3')-like ubiquitination activity in vitro, but this activity was abolished in recombinant
UFD2
truncated at the
granzyme B
/caspase 6 cleavage site. Cleavage of
UFD2
by caspases or
granzyme B
within this putative regulatory N-terminal domain might have important functional consequences within the apoptotic cascade.
...
PMID:The human homologue of the yeast polyubiquitination factor Ufd2p is cleaved by caspase 6 and granzyme B during apoptosis. 1180 88